BMT CTN 1903 (H-49760)
Administration of HIV-specific T cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue -Auto-RESIST BMT CTN PROTOCOL 1903 (AMC-109)
This is a Phase II multi-center trial single arm trial of autologous transplantation (ASCT) followed by administration of HST-NEETs for treatment of HIV associated lymphoma
Age requirements: 15 years and older (child, adult, older adult)
More information about this study can be found on clinicaltrials.gov.
NCT#/ClinicalTrials.gov ID: NCT04975698
Phone 1: 713–441–3942